<DOC>
	<DOCNO>NCT00365313</DOCNO>
	<brief_summary>The purpose study compare effect Esomeparzole Placebo Prevention Recurrent Ulcer Bleeding Patients Receiving COX-2 Inhibitor</brief_summary>
	<brief_title>Preventing Recurrent Ulcer Bleeding Arthritis Patients Using Esomeprazole Plus Celecoxib</brief_title>
	<detailed_description>Among patient previous ulcer bleeding , neither nonsteroidal anti-inflammatory drug ( NSAIDs ) plus proton pump inhibitor ( PPI ) cyclooxygenase ( COX ) -2 inhibitor adequately prevent recurrent ulcer bleeding . The aim investigate whether add PPI COX-2 inhibitor superior COX-2 inhibitor alone prevention recurrent ulcer bleed high-risk patient . Patients arthritis present NSAID-induced ulcer bleed eligible healed ulcer follow-up endoscopy ; H. pylorus negative eradicate ; require regular NSAIDs . After ulcer heal , patient receive celecoxib 200 mg b.i.d . They randomly assign esomeprazole 20 mg b.i.d . placebo 12 month . The primary endpoint recurrent ulcer bleed . Results Intention-to-treat analysis include 273 patient ( 137 receive esomeprazole 136 receive placebo ) . Recurrent ulcer bleeding occur none receiving esomeprazole 8 patient receive placebo . The 12-month cumulative incidence recurrent bleed 0 % esomeprazole group 8.9 % placebo group ( difference , 8.9 percentage point ; 95 % confidence interval difference , 4.1 13.7 ; P=0.0004 ) . During follow-up , 16.1 % patient esomeprazole group 15.4 % placebo group use low-dose aspirin . Among patient use aspirin , cumulative incidence recurrent ulcer bleed 0 % esomeprazole group 7.1 % placebo group ( difference , 7.1 percentage point ; 95 % confidence interval , 2.4 11.8 ; P=0.004 ) . Conclusion Among patient arthritis previous NSAID-induced ulcer bleeding , add PPI COX-2 inhibitor superior COX-2 inhibitor alone prevention recurrent ulcer bleeding .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>The inclusion criterion ulcer heal confirm followup endoscopy , negative test Helicobacter pylorus successful eradication Helicobacter pylorus base histology , anticipate regular use NSAIDs duration trial . The exclusion criterion concomitant use lowdose aspirin , anticoagulant corticosteroid ; history gastric duodenal surgery patch repair ; presence erosive esophagitis , gastric outlet obstruction , renal failure ( define serum creatinine level 2.26 mg per deciliter ) , terminal illness , cancer . The exclusion criterion concomitant use lowdose aspirin , anticoagulant corticosteroid ; history gastric duodenal surgery patch repair ; presence erosive esophagitis , gastric outlet obstruction , renal failure ( define serum creatinine level 2.26 mg per deciliter ) , terminal illness , cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>celecoxib</keyword>
	<keyword>oesomeprazole</keyword>
	<keyword>arthritis</keyword>
	<keyword>ulcer bleeding</keyword>
</DOC>